These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 871864)

  • 1. Hyperpigmentation associated with oxprenolol administration.
    Harrower AD; Strong JA
    Br Med J; 1977 Jul; 2(6082):296. PubMed ID: 871864
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular reaction to oxprenolol. A case report.
    Lewis BS; Setzen M; Kokoris N
    S Afr Med J; 1976 Mar; 50(12):482-3. PubMed ID: 131980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eruption during treatment with oxprenolol.
    Levene GM; Gange RW
    Br Med J; 1978 Mar; 1(6115):784. PubMed ID: 147124
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Oxprenolol and a psoriasis-like eruption.
    Leonard JC
    Lancet; 1975 Mar; 1(7907):630. PubMed ID: 47968
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxprenolol and retroperitoneal fibrosis.
    McClusky DR; Donaldson RA; McGeown MG
    Br Med J; 1980 Nov; 281(6253):1459-60. PubMed ID: 7437836
    [No Abstract]   [Full Text] [Related]  

  • 7. [Irreversible cardiogenic shock in a patient with implanted pacemaker following on oral dose of oxprenolol (Coretal-Polfa)].
    Smulski H; Sawiński J; Fiedorowicz-Fabrycy I
    Kardiol Pol; 1975; 18(2):187-9. PubMed ID: 1133894
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombocytopenia due to oxprenolol.
    Hare DL; Hicks BH
    Med J Aust; 1979 Sep; 2(5):259. PubMed ID: 514164
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombocytopenia secondary to oxprenolol, a beta-blocking agent.
    Patrassi GM; Casonato A; Fabris F; Girolami A
    Acta Haematol; 1982; 68(1):75-6. PubMed ID: 6812363
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol, oxprenolol, and sclerosing peritonitis.
    Marigold JH; Pounder RE; Pemberton J; Thompson RP
    Br Med J (Clin Res Ed); 1982 Mar; 284(6319):870. PubMed ID: 6802333
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulatory collapse after oral oxprenolol.
    Brooks NH
    Br Med J; 1975 Oct; 4(5987):24. PubMed ID: 1174909
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombocytopenia due to slow-release oxprenolol.
    Dodds WN; Davidson RJ
    Lancet; 1978 Sep; 2(8091):683. PubMed ID: 80613
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug fever due to oxprenolol.
    Hasegawa K; Sakamoto Y; Mitsunaga K; Kashiwagi H
    Br Med J; 1980 Jul; 281(6232):27-8. PubMed ID: 7407486
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
    Forrest WA
    Scott Med J; 1976 Jan; 21(1):28-30. PubMed ID: 1257736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperpigmentation with daunorubicin therapy.
    Kelly TM; Fishman LM; Lessner HE
    Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible hyperpigmentation associated with high dose hydroxyurea.
    Majumdar G; Heard SE; Slater NG
    BMJ; 1990 Jun; 300(6737):1468. PubMed ID: 2379018
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive pleural thickening during oxprenolol therapy.
    Page RL
    Br J Dis Chest; 1979 Apr; 73(2):195-9. PubMed ID: 534607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxprenolol in hypertension.
    Marshall AJ; Barritt DW
    Br J Clin Pract; 1973 Sep; 27(9):337-40. PubMed ID: 4595073
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF; LaBrooy J; Munro-Faure AD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ungual hyperpigmentation as the only sign of bleomycin poisoning].
    Veraldi S; Renzi D; Schianchi R; Sala F; Marini D
    G Ital Dermatol Venereol; 1987 Sep; 122(9):443-5. PubMed ID: 2445668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.